<DOC>
	<DOC>NCT01120418</DOC>
	<brief_summary>The objective of this study is to evaluate the effect on corneal endothelial cell density changes when ISV-403 is administered for five (5) days compared to no drug treatment, in healthy subjects.</brief_summary>
	<brief_title>Corneal Endothelial Cell Density Changes In Healthy Subjects, When Administered ISV-403 for 5 Days</brief_title>
	<detailed_description />
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid</mesh_term>
	<criteria>Must have pinholed Snellen visual acuity equal to or better than 20/40, in both eyes Must be in good health (no current or past relevant medical/ocular history) based on the judgment of the Investigator Must be willing to discontinue contact lens wear for the duration of the study Known hypersensitivity to fourth generation fluoroquinolone (SS734) or to any of the ingredients in the study medication Investigator determines could interfere with the study History of extended or continuous wear contact lens use other than silicone hydrogels History of intraocular surgery Any topical ophthalmic medication, including tear substitutes, that cannot be discontinued during the study Participation in an ophthalmic drug or device research study within the 30 days prior to entry in this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Endothelial cell density</keyword>
	<keyword>screening</keyword>
</DOC>